• Users Online: 1118
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
This article has been cited by
1Haematological profiles after Intensive phase of Anti Koch Treatment with special emphasis on bone marrow changes
Debjani Basu,Saumitra Biswas,Rudranarayan Ray
Indian Journal of Tuberculosis.2020;()
[DOI]
2Prevalence of adverse drug reaction with first-line drugs among patients treated for pulmonary tuberculosis
Abhijeet Singh,Rajendra Prasad,Viswesvaran Balasubramanian,Nikhil Gupta,Pawan Gupta
Clinical Epidemiology and Global Health.2015;3()S80
[DOI]
3Prevalence of adverse drug reaction with first-line drugs among patients treated for pulmonary tuberculosis
Sunil Munakomi,Giovanni Grasso,Rojeena Chapagain
Clinical Epidemiology and Global Health.2020;1271()29
[DOI]
4THE ANTITUBERCULAR DRUG INDUCED ADVERSE EFFECTS IN REGISTERED CASES UNDER RNTCP – DOTS, PROGRAMME IN BIJAPUR
Nemagouda S
Journal of Evolution of Medical and Dental Sciences.2014;3(19)5255
[DOI]
5‘Have we missed reporting adverse drug reactions under Revised National TB Control Programme?’ - A mixed method study in Bengaluru, India
Lalitha Krishnappa,Suman Gadicherla,Priyadarshini Chidambaram,H.V. Anuradha,Shivaraj Nallur Somanna,Poonam Ramesh Naik,Arundhati Das,Somashekar Narasimhaiah,Sharath Burugina Nagaraja
Indian Journal of Tuberculosis.2020;67(1)20
[DOI]
Feedback
Subscribe

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal